Myeloproliferative neoplasm epidemiology and demographics: Difference between revisions
No edit summary |
|||
Line 7: | Line 7: | ||
===Incidence=== | ===Incidence=== | ||
The incidence of myeloproliferative neoplasm is approximately 7.8 per 100,000 individuals worldwide.<ref name="CDC">Centers for Disease Control and Prevention. WTC Health Program.Myeloid Malignancieshttp://www.cdc.gov/wtc/pdfs/WTCHP_PP_MyeloidMalignancies_02012014.pdf</ref> | The incidence of myeloproliferative neoplasm is approximately 7.8 per 100,000 individuals worldwide.<ref name="CDC">Centers for Disease Control and Prevention. WTC Health Program.Myeloid Malignancieshttp://www.cdc.gov/wtc/pdfs/WTCHP_PP_MyeloidMalignancies_02012014.pdf</ref> | ||
===Age=== | |||
The prevalence of myeloproliferative neoplasm increases with age. | |||
===Gender=== | |||
Males are more commonly affected with myeloproliferative neoplasm than females. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 17:11, 22 October 2015
Myeloproliferative Neoplasm Microchapters |
Differentiating myeloproliferative neoplasm from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Myeloproliferative neoplasm epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Myeloproliferative neoplasm epidemiology and demographics |
FDA on Myeloproliferative neoplasm epidemiology and demographics |
on Myeloproliferative neoplasm epidemiology and demographics |
Myeloproliferative neoplasm epidemiology and demographics in the news |
Blogs on Myeloproliferative neoplasm epidemiology and demographics |
Directions to Hospitals Treating Myeloproliferative neoplasm |
Risk calculators and risk factors for Myeloproliferative neoplasm epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
The incidence of myeloproliferative neoplasm is approximately 7.8 per 100,000 individuals worldwide.[1]
Epidemiology and Demographics
Incidence
The incidence of myeloproliferative neoplasm is approximately 7.8 per 100,000 individuals worldwide.[1]
Age
The prevalence of myeloproliferative neoplasm increases with age.
Gender
Males are more commonly affected with myeloproliferative neoplasm than females.